2025 Fall Conference | Florbetapir F 18 Live Reader Training by Eli Lilly and Company Date Saturday 11/08/25 Time 08:00 AM - 10:30 AM PDT Add To Calendar Session Format This program will be presented in-person only On Demand This program is not expected to be available in the meeting's On Demand product. Event Type Industry Therapeutic Update Topic(s) General Neurology Learning Objectives Florbetapir F 18 is a radioactive diagnostic agent for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. Florbetapir F 18 reader training aims to equip attendees with essential skills for accurately interpreting florbetapir amyloid PET scans. To register for this training, visit https://meetings.lilly.com/aaMa9q?rt=uq6SEWjzbEy0Iv6UOhUJSA. CME Available No CME available Program Materials Event Timeline No timeline events available at this time. Faculty Disclosures